Dr. Jubilee Purkayastha (ডঃ জুবিলী পুৰকায়স্থ) is a part of the DRDO team which is involved in the process of developing Anti-Covid Drug 2-DG. Dr. Jubilee Purkayastha (DRDO), a scientist from our North Karimganj Mahishasan and proud of the people of India, is one of the few scientists in India to have developed a corona 2-DG drug to get rid of the dreaded virus called the corona.
She was the World Academic Champion -2018 in Molecular Biology and Biotechnology.
Meanwhile, she is presently serving as a Scientist at the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organization (DRDO), Delhi, India.
According to reports, World Champion, Dr. Jubilee Purkayastha is a Scientist at Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organization (DRDO), Delhi. Dr. Purkayastha is a PhD in Life Sciences and is known for her contributions to the area of Plant Biotechnology, particularly in Proteomics and Genomics. Dr. Purkayastha has more than 25 research publications, 1 patent, 2 books and two awards to her credit. She is an expert reviewer for several International Peer Reviewed Journals like Ecotoxicology (Springer), Plos One, Acta Physiologiae Plantarum (Springer), Plant Molecular Biology Reporter (Springer) and also sits on the editorial board of several International Journals.
Dr Jubilee was a student of Karimganj College. She did her PhD from North East Institute of Science and Technology in Jorhat and joined the Defense Research Laboratory of DRDO in Tezpur as a scientist in 2008.
The daughter of Lt. Sudarshan Purkayastha & Mrs. Binoy Kumari Purkayastha is the one who is actively involve in the process of discovering DRDO Anti Covid Drug 2-DG to save humanity from the ferocious virus Covid.
She also wrote a book namely “Bioprospecting of Indigenous Bioresources of North-East India” describing the less and merely explored part of the indigenous biodiversity of NE India with an explanation towards their better sustainable exploitation for the benefit of the people and society.
What is Anti-Covid Drug 2-DG?
As per reports, DRDO’s new anti-Covid oral drug, 2-deoxy-D-glucose (2-DG), was recently granted emergency use approval by the Drug Controller General of India (DCGI) as an adjunct therapy in moderate cases of COVID-19. The 2-DG drug is expected to help hospitalized COVID-19 patients and reduce their supplemental oxygen dependence.
Generic drugmaker Dr. Reddy’s Laboratories, which had developed 2-deoxy-D-glucose (2DG) as an anti-Covid-19 drug in collaboration with the Defence Research and Development Organisation, has warned the public against spurious or illegal products in the name of 2DG.
The anti-Covid oral drug has been developed by DRDO’s leading laboratory — Institute of Nuclear Medicine and Allied Sciences — in collaboration with Dr Reddy’s Laboratories
How can 2-DG be consumed?
The anti-COVID drug 2-DG has been developed in powder form and is ingested orally by dissolving it in water. As per Dr Sudhir Chandna, DRDO Project Director and Scientist of 2-DG, it can be consumed twice a day.